Development of alfuzosin gastro resistant prolonged release tablet and evaluate using HPLC
Alfuzosin belongs to a class of drugs known as alpha blockers. As an antagonist of the alpha 1 adrenergic receptor, it works by relaxing the muscles in the prostate and bladder neck, making it easier to urinate. Alfuzosin gastro resistant prolonged release tablet was prepared as the prepared tablet will improve the bioavailability as well dosing frequency. The prepared gastro resistant prolonged release tablet was evaluated using HPLC. The release profile of each film coated prolonged release tablet contains Alfuzosin HCl IP. 10 mg was found to be range from 23.27 % to 93.58 % from 1st hour to 20th Hour of the release time. From the above study it was concluded that the prolonged release tablet of alfuzosin was found to be effective for long term therapy.
Keywords: Alfuzosin, Gastro Resistant, Prolonged Release, HPLC
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).